Hainan Shuangcheng Pharmaceut Strategic Asset Allocation Index
Hainan Shuangcheng Pharmaceut strategic asset allocation index. Hainan Shuangcheng Pharmaceut (002693) has a Strategic Asset Allocation Index of 79.6% as of September 2023. Strategic assets (PP&E of CN¥459.07 Million plus long-term investments of CN¥-) total CN¥459.07 Million, measured against net assets of CN¥576.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 002693 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hainan Shuangcheng Pharmaceut (2009–2022)
Strategic asset allocation index of Hainan Shuangcheng Pharmaceut from 2009 to 2022. This chart shows how Hainan Shuangcheng Pharmaceut's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of September 2023, the index stands at 79.6%, representing strategic assets of CN¥459.07 Million against net assets of CN¥576.86 Million CNY. Check tangible net worth ratio of Hainan Shuangcheng Pharmaceut to evaluate the tangible quality of the company's equity base.
Hainan Shuangcheng Pharmaceut Strategic Asset Allocation Index by Year (2009–2022)
Hainan Shuangcheng Pharmaceut strategic asset allocation index by year from 2009 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Hainan Shuangcheng Pharmaceut from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hainan Shuangcheng Pharmaceut market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 81.2% | CN¥471.77 Million | CN¥471.77 Million | CN¥- | CN¥580.94 Million | ▼ -7.8 pp |
| 2021 | 89.1% | CN¥504.73 Million | CN¥504.73 Million | CN¥- | CN¥566.75 Million | ▼ -1.4 pp |
| 2020 | 90.4% | CN¥541.00 Million | CN¥541.00 Million | CN¥- | CN¥598.31 Million | ▲ +1.8 pp |
| 2019 | 88.6% | CN¥601.10 Million | CN¥601.10 Million | CN¥- | CN¥678.26 Million | ▼ -6.6 pp |
| 2018 | 95.2% | CN¥637.82 Million | CN¥637.82 Million | CN¥- | CN¥669.69 Million | ▲ +6.0 pp |
| 2017 | 89.2% | CN¥679.52 Million | CN¥679.52 Million | CN¥- | CN¥761.71 Million | ▼ -67.3 pp |
| 2016 | 156.6% | CN¥865.94 Million | CN¥658.94 Million | CN¥207.00 Million | CN¥553.13 Million | ▲ +57.3 pp |
| 2015 | 99.2% | CN¥920.54 Million | CN¥443.22 Million | CN¥477.31 Million | CN¥927.61 Million | ▲ +69.7 pp |
| 2014 | 29.6% | CN¥264.15 Million | CN¥264.15 Million | CN¥- | CN¥893.55 Million | ▲ +4.4 pp |
| 2013 | 25.2% | CN¥219.12 Million | CN¥219.12 Million | CN¥- | CN¥870.62 Million | ▲ +2.9 pp |
| 2012 | 22.2% | CN¥188.07 Million | CN¥188.07 Million | CN¥- | CN¥845.85 Million | ▼ -39.1 pp |
| 2011 | 61.3% | CN¥139.94 Million | CN¥139.94 Million | CN¥- | CN¥228.23 Million | ▲ +27.0 pp |
| 2010 | 34.3% | CN¥54.20 Million | CN¥54.20 Million | CN¥- | CN¥157.82 Million | ▼ -34.2 pp |
| 2009 | 68.5% | CN¥53.43 Million | CN¥53.43 Million | CN¥- | CN¥77.95 Million | — |